Cargando…
Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior()()
Levetiracetam (LEV) is a novel antiepileptic drug (AED) approved for the adjunctive treatment of generalized and partial seizures. LEV has no clinically significant drug interactions and has limited adverse effects. The psychiatric adverse effects of LEV include de novo psychosis, affective disorder...
Autores principales: | Kaufman, Kenneth R., Bisen, Viwek, Zimmerman, Aphrodite, Tobia, Anthony, Mani, Ram, Wong, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150644/ https://www.ncbi.nlm.nih.gov/pubmed/25667841 http://dx.doi.org/10.1016/j.ebcr.2013.07.002 |
Ejemplares similares
-
Delusional parasitosis on the psychiatric consultation service – a longitudinal perspective: case study
por: Trenton, Adam, et al.
Publicado: (2017) -
Are doses of lamotrigine or levetiracetam adjusted during pregnancy?
por: Richards, Noni, et al.
Publicado: (2017) -
Levetiracetam-induced rage and suicidality: Two case reports and review of literature
por: Molokwu, Orakwue A., et al.
Publicado: (2015) -
Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()()
por: Kaufman, Kenneth R., et al.
Publicado: (2012) -
Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats
por: Barnes Heller, Heidi, et al.
Publicado: (2018)